Physical activity is one of the most powerful interventions in cardiovascular and metabolic medicine. The evidence has been accumulating for decades. And yet, in the average clinical encounter, exercise still gets delivered as a sentence, not a prescription.
That gap is not a mystery. It is a design problem. And understanding why it persists is the first step toward fixing it.
The evidence is not the problem
In 2015, a landmark meta-analysis published in the Annals of Internal Medicine examined sedentary behavior across a cohort of more than 47,000 individuals. The findings were striking: prolonged sitting was independently associated with higher risks of cardiovascular disease, type 2 diabetes, cancer, and premature death, even after physical activity was accounted for.
That same body of evidence has been reinforced repeatedly. A comprehensive systematic review by Pedersen and Saltin, published in the Scandinavian Journal of Medicine and Science in Sports, documented the clinical evidence for exercise prescription across 26 different chronic diseases, including coronary artery disease, heart failure, hypertension, type 2 diabetes, obesity, depression, and cancer.
The science is not the bottleneck. The system is.
Exercise is Medicine, a movement in the right direction
One of the most important attempts to close this gap came in 2007, when the American College of Sports Medicine and the American Medical Association launched the Exercise is Medicine initiative. The goal was straightforward: make physical activity assessment a standard part of every clinical encounter. Ask the patient. Record the answer. Act on it.
Over the past two decades, Exercise is Medicine has created meaningful momentum. Vital sign tools for documenting activity levels have been adopted in some healthcare systems. Provider education programs have been developed. The initiative established the clinical vocabulary that now anchors serious conversations about prevention.
Asking the question is not the same as managing the answer.
A patient who reports sedentary behavior at a visit may receive a recommendation to work toward 150 minutes of moderate activity per week. That recommendation may be appropriate and evidence-based. But if no system exists to understand whether the patient started, whether the activity was appropriate, whether they progressed, or whether the change was sustained, the prescription has not been filled in any meaningful clinical sense.
Exercise is Medicine identified the problem correctly. The infrastructure required to solve it is still being built.
Cardiac rehabilitation: proof of concept, not proof of scale
If Exercise is Medicine represents the aspiration, cardiac rehabilitation represents the gold standard of what clinical exercise delivery can look like when it is properly resourced.
Cardiac rehabilitation combines structured, supervised physical activity with education, risk factor management, psychological support, and longitudinal follow-up. The outcomes are well documented: reduced mortality, reduced hospitalization, improved functional capacity, and better quality of life. It works.
It also reaches only a fraction of the people who could benefit from it. Research examining the relationship between cardiovascular risk-reduction program capacity and population need in Ontario found a fundamental mismatch. When incident diabetes was included alongside cardiac diagnoses, the eligible population reached approximately 128,000 individuals annually, while available program capacity covered fewer than 14 percent.
This is not an Ontario problem alone. It is a structural feature of how healthcare systems have historically approached exercise: as a specialist service, delivered in person, resourced for the acutely ill, and disconnected from the vast middle of people with subclinical risk, early-stage disease, or multiple comorbidities.
The nuance that most platforms miss
Consumer wellness applications have expanded rapidly. Many are well designed, well funded, and genuinely useful for some populations. But access to workout content is not the same as clinical exercise management.
Did this patient improve from their baseline?
Was that improvement appropriate given their cardiac, metabolic, and musculoskeletal profile?
Was it sustained?
What does it predict about downstream risk?
These are clinical questions, and they require clinical architecture. The key concept is dose. Exercise dose, meaning frequency, intensity, duration, and progression relative to baseline, is what transforms physical activity from a general behavior into a clinically measurable intervention.
A 68-year-old with prior myocardial infarction, low cardiorespiratory fitness, and osteoarthritis is not the same clinical situation as a 45-year-old with hypertension and metabolic syndrome. The prescription matters. So do the tracking, the feedback, and the integration with the rest of care.
This is the gap that neither general wellness platforms nor traditional rehabilitation programs fully occupy: the space between advice and infrastructure, between a recommendation and a managed clinical behavior.
What closing the gap requires
Making exercise clinically meaningful, not just clinically recommended, requires capabilities that healthcare still lacks at scale.
- A longitudinal measurement system. Not a single question about weekly activity, but a way to track exercise behavior over time, understand trajectories, and detect meaningful change from baseline.
- Clinical integration. The information needs to reach the care team in a form that is interpretable and actionable, not a data dump, but a signal.
- Appropriate populations, not just motivated ones. The value of clinical exercise infrastructure is greatest in sedentary, high-risk, cardiometabolically compromised populations that have the most to gain and the most barriers to entry.
- Economic accountability. Prevention needs to be measurable enough to justify investment. If the impact of exercise-based prevention on healthcare utilization, pharmacy spend, and downstream cardiovascular events cannot be tracked, it will remain peripheral to how payers and health systems allocate resources.
None of these requirements are technologically impossible. They are operationally underdeveloped.
Why this moment matters
Two converging forces are creating an unusual window for progress. First, the scale of cardiometabolic disease is reshaping payer economics in ways that are difficult to ignore. The rise of GLP-1 medications has brought renewed attention to upstream prevention: these drugs are expensive, widely prescribed, and most effective when combined with lifestyle intervention. That combination is not yet systematically delivered.
Second, digital infrastructure has matured. Longitudinal tracking, clinical reporting, population-level analytics, and remote care delivery are operationally feasible in ways they were not a decade ago.
The missing piece is not the evidence that exercise works, or the technology to support it. The missing piece is the clinical architecture that connects the two and makes exercise behavior visible, interpretable, and accountable within the care system.
Frequently asked questions
Why hasn't Exercise is Medicine solved the clinical exercise gap?
Exercise is Medicine established the case for treating physical activity as a vital sign and created important momentum in provider education. Documentation, however, is not the same as management, and the infrastructure to act on that conversation at scale is still developing.
What makes cardiac rehabilitation different from a general exercise recommendation?
Cardiac rehabilitation combines structured physical activity with clinical supervision, risk factor management, education, and longitudinal follow-up. It is a managed care pathway, not a recommendation. Its limitations are those of capacity and access, not clinical model.
What is exercise dose and why does it matter clinically?
Exercise dose refers to the frequency, intensity, duration, and type of physical activity relative to an individual's baseline. It matters because the same activity level represents a very different intervention depending on where the patient starts.
What is the gap between wellness platforms and clinical exercise?
Wellness platforms generally support engagement, motivation, and activity tracking for the general population. Clinical exercise management requires baseline-referenced measurement, integration with the care team, population-appropriate risk stratification, and accountability for outcomes.
Can digital health make exercise part of clinical care?
Digital tools can extend reach, support longitudinal tracking, and generate interpretable data for care teams, but only if they are designed around clinical questions rather than consumer engagement metrics.
References
- Biswas A, Oh PI, Faulkner GE, et al. Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med. 2015;162(2):123-132.
- Pedersen BK, Saltin B. Exercise as medicine: evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25 Suppl 3:1-72.
- Candido E, Alter DA, Oh PI, et al. The relationship between need and capacity for multidisciplinary cardiovascular risk-reduction programs in Ontario. Can J Cardiol. 2011;27(2):200-207.
- Alter DA, et al. The implementation of a value-based learning health system for preventative care in Ontario, Canada. Am J Cardiovasc Dis. 2023.
- Alter DA. From insight to infrastructure: managing cardiorespiratory fitness. J Am Coll Cardiol. 2026.
- Sallis R. Exercise is medicine and physicians need to prescribe it. Br J Sports Med. 2009;43(1):3-4.